Global Neprilysin Market Growth 2025-2031

October 2025 | 85 pages | ID: G56F58704293EN
LP Information

Abstracts

The global Neprilysin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Neprilysin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Neprilysin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Neprilysin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Neprilysin players cover Bioprojet SCR, Novartis AG, Pharmaleads SA, Theravance Biopharma Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Neprilysin Industry Forecast? looks at past sales and reviews total world Neprilysin sales in 2024, providing a comprehensive analysis by region and market sector of projected Neprilysin sales for 2025 through 2031. With Neprilysin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neprilysin industry.

This Insight Report provides a comprehensive analysis of the global Neprilysin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neprilysin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Neprilysin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neprilysin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neprilysin.

This report presents a comprehensive overview, market shares, and growth opportunities of Neprilysin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• TD-0714
• STR-324
• PL-265
• LHW-090
• Others

Segmentation by Application:

• Acute Heart Failure
• Cancer Pain
• Hypertension
• Alzheimer's Disease
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Bioprojet SCR
• Novartis AG
• Pharmaleads SA
• Theravance Biopharma Inc

Key Questions Addressed in this Report

What is the 10-year outlook for the global Neprilysin market?
What factors are driving Neprilysin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neprilysin market opportunities vary by end market size?
How does Neprilysin break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Neprilysin Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Neprilysin by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Neprilysin by Country/Region, 2020, 2024 & 2031
2.2 Neprilysin Segment by Type
  2.2.1 TD-0714
  2.2.2 STR-324
  2.2.3 PL-265
  2.2.4 LHW-090
  2.2.5 Others
2.3 Neprilysin Sales by Type
  2.3.1 Global Neprilysin Sales Market Share by Type (2020-2025)
  2.3.2 Global Neprilysin Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Neprilysin Sale Price by Type (2020-2025)
2.4 Neprilysin Segment by Application
  2.4.1 Acute Heart Failure
  2.4.2 Cancer Pain
  2.4.3 Hypertension
  2.4.4 Alzheimer's Disease
  2.4.5 Others
2.5 Neprilysin Sales by Application
  2.5.1 Global Neprilysin Sale Market Share by Application (2020-2025)
  2.5.2 Global Neprilysin Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Neprilysin Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Neprilysin Breakdown Data by Company
  3.1.1 Global Neprilysin Annual Sales by Company (2020-2025)
  3.1.2 Global Neprilysin Sales Market Share by Company (2020-2025)
3.2 Global Neprilysin Annual Revenue by Company (2020-2025)
  3.2.1 Global Neprilysin Revenue by Company (2020-2025)
  3.2.2 Global Neprilysin Revenue Market Share by Company (2020-2025)
3.3 Global Neprilysin Sale Price by Company
3.4 Key Manufacturers Neprilysin Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Neprilysin Product Location Distribution
  3.4.2 Players Neprilysin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NEPRILYSIN BY GEOGRAPHIC REGION

4.1 World Historic Neprilysin Market Size by Geographic Region (2020-2025)
  4.1.1 Global Neprilysin Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Neprilysin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Neprilysin Market Size by Country/Region (2020-2025)
  4.2.1 Global Neprilysin Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Neprilysin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Neprilysin Sales Growth
4.4 APAC Neprilysin Sales Growth
4.5 Europe Neprilysin Sales Growth
4.6 Middle East & Africa Neprilysin Sales Growth

5 AMERICAS

5.1 Americas Neprilysin Sales by Country
  5.1.1 Americas Neprilysin Sales by Country (2020-2025)
  5.1.2 Americas Neprilysin Revenue by Country (2020-2025)
5.2 Americas Neprilysin Sales by Type (2020-2025)
5.3 Americas Neprilysin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Neprilysin Sales by Region
  6.1.1 APAC Neprilysin Sales by Region (2020-2025)
  6.1.2 APAC Neprilysin Revenue by Region (2020-2025)
6.2 APAC Neprilysin Sales by Type (2020-2025)
6.3 APAC Neprilysin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Neprilysin by Country
  7.1.1 Europe Neprilysin Sales by Country (2020-2025)
  7.1.2 Europe Neprilysin Revenue by Country (2020-2025)
7.2 Europe Neprilysin Sales by Type (2020-2025)
7.3 Europe Neprilysin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Neprilysin by Country
  8.1.1 Middle East & Africa Neprilysin Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Neprilysin Revenue by Country (2020-2025)
8.2 Middle East & Africa Neprilysin Sales by Type (2020-2025)
8.3 Middle East & Africa Neprilysin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neprilysin
10.3 Manufacturing Process Analysis of Neprilysin
10.4 Industry Chain Structure of Neprilysin

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Neprilysin Distributors
11.3 Neprilysin Customer

12 WORLD FORECAST REVIEW FOR NEPRILYSIN BY GEOGRAPHIC REGION

12.1 Global Neprilysin Market Size Forecast by Region
  12.1.1 Global Neprilysin Forecast by Region (2026-2031)
  12.1.2 Global Neprilysin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Neprilysin Forecast by Type (2026-2031)
12.7 Global Neprilysin Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Bioprojet SCR
  13.1.1 Bioprojet SCR Company Information
  13.1.2 Bioprojet SCR Neprilysin Product Portfolios and Specifications
  13.1.3 Bioprojet SCR Neprilysin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Bioprojet SCR Main Business Overview
  13.1.5 Bioprojet SCR Latest Developments
13.2 Novartis AG
  13.2.1 Novartis AG Company Information
  13.2.2 Novartis AG Neprilysin Product Portfolios and Specifications
  13.2.3 Novartis AG Neprilysin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Novartis AG Main Business Overview
  13.2.5 Novartis AG Latest Developments
13.3 Pharmaleads SA
  13.3.1 Pharmaleads SA Company Information
  13.3.2 Pharmaleads SA Neprilysin Product Portfolios and Specifications
  13.3.3 Pharmaleads SA Neprilysin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Pharmaleads SA Main Business Overview
  13.3.5 Pharmaleads SA Latest Developments
13.4 Theravance Biopharma Inc
  13.4.1 Theravance Biopharma Inc Company Information
  13.4.2 Theravance Biopharma Inc Neprilysin Product Portfolios and Specifications
  13.4.3 Theravance Biopharma Inc Neprilysin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Theravance Biopharma Inc Main Business Overview
  13.4.5 Theravance Biopharma Inc Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Neprilysin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Neprilysin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of TD-0714
Table 4. Major Players of STR-324
Table 5. Major Players of PL-265
Table 6. Major Players of LHW-090
Table 7. Major Players of Others
Table 8. Global Neprilysin Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Neprilysin Sales Market Share by Type (2020-2025)
Table 10. Global Neprilysin Revenue by Type (2020-2025) & ($ million)
Table 11. Global Neprilysin Revenue Market Share by Type (2020-2025)
Table 12. Global Neprilysin Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Neprilysin Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Neprilysin Sale Market Share by Application (2020-2025)
Table 15. Global Neprilysin Revenue by Application (2020-2025) & ($ million)
Table 16. Global Neprilysin Revenue Market Share by Application (2020-2025)
Table 17. Global Neprilysin Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Neprilysin Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Neprilysin Sales Market Share by Company (2020-2025)
Table 20. Global Neprilysin Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Neprilysin Revenue Market Share by Company (2020-2025)
Table 22. Global Neprilysin Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Neprilysin Producing Area Distribution and Sales Area
Table 24. Players Neprilysin Products Offered
Table 25. Neprilysin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Neprilysin Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Neprilysin Sales Market Share Geographic Region (2020-2025)
Table 30. Global Neprilysin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Neprilysin Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Neprilysin Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Neprilysin Sales Market Share by Country/Region (2020-2025)
Table 34. Global Neprilysin Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Neprilysin Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Neprilysin Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Neprilysin Sales Market Share by Country (2020-2025)
Table 38. Americas Neprilysin Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Neprilysin Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Neprilysin Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Neprilysin Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Neprilysin Sales Market Share by Region (2020-2025)
Table 43. APAC Neprilysin Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Neprilysin Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Neprilysin Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Neprilysin Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Neprilysin Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Neprilysin Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Neprilysin Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Neprilysin Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Neprilysin Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Neprilysin Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Neprilysin Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Neprilysin
Table 55. Key Market Challenges & Risks of Neprilysin
Table 56. Key Industry Trends of Neprilysin
Table 57. Neprilysin Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Neprilysin Distributors List
Table 60. Neprilysin Customer List
Table 61. Global Neprilysin Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Neprilysin Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Neprilysin Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Neprilysin Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Neprilysin Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Neprilysin Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Neprilysin Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Neprilysin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Neprilysin Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Neprilysin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Neprilysin Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Neprilysin Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Neprilysin Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Neprilysin Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Bioprojet SCR Basic Information, Neprilysin Manufacturing Base, Sales Area and Its Competitors
Table 76. Bioprojet SCR Neprilysin Product Portfolios and Specifications
Table 77. Bioprojet SCR Neprilysin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Bioprojet SCR Main Business
Table 79. Bioprojet SCR Latest Developments
Table 80. Novartis AG Basic Information, Neprilysin Manufacturing Base, Sales Area and Its Competitors
Table 81. Novartis AG Neprilysin Product Portfolios and Specifications
Table 82. Novartis AG Neprilysin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Novartis AG Main Business
Table 84. Novartis AG Latest Developments
Table 85. Pharmaleads SA Basic Information, Neprilysin Manufacturing Base, Sales Area and Its Competitors
Table 86. Pharmaleads SA Neprilysin Product Portfolios and Specifications
Table 87. Pharmaleads SA Neprilysin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Pharmaleads SA Main Business
Table 89. Pharmaleads SA Latest Developments
Table 90. Theravance Biopharma Inc Basic Information, Neprilysin Manufacturing Base, Sales Area and Its Competitors
Table 91. Theravance Biopharma Inc Neprilysin Product Portfolios and Specifications
Table 92. Theravance Biopharma Inc Neprilysin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Theravance Biopharma Inc Main Business
Table 94. Theravance Biopharma Inc Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Neprilysin
Figure 2. Neprilysin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neprilysin Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Neprilysin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Neprilysin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Neprilysin Sales Market Share by Country/Region (2024)
Figure 10. Neprilysin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of TD-0714
Figure 12. Product Picture of STR-324
Figure 13. Product Picture of PL-265
Figure 14. Product Picture of LHW-090
Figure 15. Product Picture of Others
Figure 16. Global Neprilysin Sales Market Share by Type in 2025
Figure 17. Global Neprilysin Revenue Market Share by Type (2020-2025)
Figure 18. Neprilysin Consumed in Acute Heart Failure
Figure 19. Global Neprilysin Market: Acute Heart Failure (2020-2025) & (K Pcs)
Figure 20. Neprilysin Consumed in Cancer Pain
Figure 21. Global Neprilysin Market: Cancer Pain (2020-2025) & (K Pcs)
Figure 22. Neprilysin Consumed in Hypertension
Figure 23. Global Neprilysin Market: Hypertension (2020-2025) & (K Pcs)
Figure 24. Neprilysin Consumed in Alzheimer's Disease
Figure 25. Global Neprilysin Market: Alzheimer's Disease (2020-2025) & (K Pcs)
Figure 26. Neprilysin Consumed in Others
Figure 27. Global Neprilysin Market: Others (2020-2025) & (K Pcs)
Figure 28. Global Neprilysin Sale Market Share by Application (2024)
Figure 29. Global Neprilysin Revenue Market Share by Application in 2025
Figure 30. Neprilysin Sales by Company in 2025 (K Pcs)
Figure 31. Global Neprilysin Sales Market Share by Company in 2025
Figure 32. Neprilysin Revenue by Company in 2025 ($ millions)
Figure 33. Global Neprilysin Revenue Market Share by Company in 2025
Figure 34. Global Neprilysin Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Neprilysin Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Neprilysin Sales 2020-2025 (K Pcs)
Figure 37. Americas Neprilysin Revenue 2020-2025 ($ millions)
Figure 38. APAC Neprilysin Sales 2020-2025 (K Pcs)
Figure 39. APAC Neprilysin Revenue 2020-2025 ($ millions)
Figure 40. Europe Neprilysin Sales 2020-2025 (K Pcs)
Figure 41. Europe Neprilysin Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Neprilysin Sales 2020-2025 (K Pcs)
Figure 43. Middle East & Africa Neprilysin Revenue 2020-2025 ($ millions)
Figure 44. Americas Neprilysin Sales Market Share by Country in 2025
Figure 45. Americas Neprilysin Revenue Market Share by Country (2020-2025)
Figure 46. Americas Neprilysin Sales Market Share by Type (2020-2025)
Figure 47. Americas Neprilysin Sales Market Share by Application (2020-2025)
Figure 48. United States Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Neprilysin Sales Market Share by Region in 2025
Figure 53. APAC Neprilysin Revenue Market Share by Region (2020-2025)
Figure 54. APAC Neprilysin Sales Market Share by Type (2020-2025)
Figure 55. APAC Neprilysin Sales Market Share by Application (2020-2025)
Figure 56. China Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 60. India Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Neprilysin Sales Market Share by Country in 2025
Figure 64. Europe Neprilysin Revenue Market Share by Country (2020-2025)
Figure 65. Europe Neprilysin Sales Market Share by Type (2020-2025)
Figure 66. Europe Neprilysin Sales Market Share by Application (2020-2025)
Figure 67. Germany Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 68. France Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Neprilysin Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Neprilysin Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Neprilysin Sales Market Share by Application (2020-2025)
Figure 75. Egypt Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Neprilysin Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Neprilysin in 2025
Figure 81. Manufacturing Process Analysis of Neprilysin
Figure 82. Industry Chain Structure of Neprilysin
Figure 83. Channels of Distribution
Figure 84. Global Neprilysin Sales Market Forecast by Region (2026-2031)
Figure 85. Global Neprilysin Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Neprilysin Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Neprilysin Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Neprilysin Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Neprilysin Revenue Market Share Forecast by Application (2026-2031)